Senti Biosciences Holdings, Inc.

SNTI

Senti Biosciences Holdings, Inc.

SNTI

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2025-02-06Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:5,613,378Shares Outstanding:30,971,573Institutional Ownership Pct.:18.12%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Nonrelated Party	-	0	0	-0	0	0	0	0	-0	0	0	0
Related Party	-	0	0	-0	0	0	0	0	-0	0	0	-19
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	6	9	16	12	22	34	48	10	16	24	36	39
Short Term Investments	-	-	-	-	-	-	-	-	-	-	0	0
Assets Current	13	15	23	18	33	45	59	17	44	56	71	79
Accounts Receivable Net Noncurrent	-	-	-	-	-	-	0	0	0	0	1	1
Restricted Cash	1	4	4	4	4	4	4	4	4	4	4	6
Assets Of Disposal Group Including Discontinued Op…	-	-	-	-	-	-	-	-	-	-	0	0
Property Plant And Equipment Net	11	12	13	19	20	21	21	22	23	24	25	26
Operating Lease Right Of Use Asset	7	8	12	12	13	13	14	14	15	16	16	17
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	33	38	51	53	69	83	98	58	87	102	119	132
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	2	1	3	2	1	2	1	1	1	2	1	2
Disposal Group Including Discontinued Operation As…	-	-	-	-	-	-	-	-	-	-	0	0
Finance Lease Liability Current	-	-	-	-	-	-	0	0	0	0	0	0
Accounts Payable And Other Accrued Liabilities Cur…	4	5	5	5	4	4	6	3	3	3	6	4
Operating Lease Liability Current	3	6	5	5	5	5	5	4	4	4	4	3
Business Combination Contingent Consideration Liab…	-	-	-	-	-	-	-	0	0	-	-	-
Contract With Customer Liability Current	0	0	0	-	-	-	0	-	-	-	0	0
Liabilities Current	16	14	14	12	10	11	13	9	9	10	13	10
Finance Lease Liability Noncurrent	-	-	-	-	-	-	-	-	-	-	-	0
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	-	0	0	0	0	0	0
Operating Lease Liability Noncurrent	13	13	24	25	26	28	29	30	31	32	34	35
Other Liabilities Noncurrent	8	8	8	8	8	7	5	3	-	-	0	-
Liabilities	37	36	46	45	44	45	47	42	43	46	53	49
Business Combination Contingent Consideration Liab…	-	-	-	-	-	-	0	0	0	0	0	0
Temporary Equity Carrying Amount Attributable To P…	-	0	0	0	0	0	25	0	0	0	0	-
Derivative Liabilities Noncurrent	-	-	-	-	-	-	0	0	2	4	6	4
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	372	365	364	352	351	349	323	313	312	313	311	309
Accumulated Other Comprehensive Income Loss Net Of…	-	-	-	-	-	-	-	-	-	0	0	0
Retained Earnings Accumulated Deficit	-376	-363	-359	-344	-326	-311	-297	-297	-268	-256	-244	-226
Stockholders Equity	-3	3	6	8	25	38	26	16	44	56	67	83
Preferred Stock Value	-	-	-	-	-	-	-	0	0	0	-	0
Liabilities And Stockholders Equity	33	38	51	53	69	83	98	58	87	102	119	132
Preferred Stock Par Or Stated Value Per Share	-	-	-	-	-	-	-	0	0	0	-	0
Preferred Stock Shares Authorized	-	-	-	-	-	-	-	10	10	10	-	10
Preferred Stock Shares Issued	-	-	-	-	-	-	-	0	0	0	-	0
Preferred Stock Shares Outstanding	-	-	-	-	-	-	-	0	0	0	-	0
Temporary Equity Par Or Stated Value Per Share	-	-	0	0	0	0	0	-	-	-	0	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Temporary Equity Shares Authorized	-	0	0	0	0	0	0	-	-	-	0	-
Temporary Equity Shares Issued	-	-	0	0	0	0	0	-	-	-	0	-
Common Stock Shares Authorized	500	500	500	500	500	500	500	500	500	500	500	500
Common Stock Shares Issued	31	31	31	26	26	26	5	5	5	5	5	4
Shares Outstanding	31	31	31	26	26	26	5	5	5	5	5	4
Temporary Equity Shares Outstanding	-	0	0	0	0	0	21	0	0	0	0	-
Temporary Equity Liquidation Preference	-	-	0	0	0	0	148	-	-	-	0	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-7.21%	2.88%	-65.38%	-	-	-	-	-	-	-	-	-
2025	-4.85%	-34.55%	-41.52%	-4.55%	-9.74%	35.06%	18.99%	-38.55%	-44.13%	39.24%	27.85%	21.52%
2024	-18.92%	-25.41%	-39.19%	45.69%	13.71%	10.66%	136.05%	84.55%	87.12%	-7.12%	-7.12%	9.40%
2023	-	-	-	-	-	-	22.86%	74.29%	31.43%	-27.87%	-21.49%	-40.21%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.83	1.04	1.67	1.51	3.26	4.22	4.49	1.92	4.89	5.79	5.62	7.81
Quick Ratio	0.83	1.04	1.67	1.51	3.26	4.22	4.49	1.92	4.89	5.79	5.62	7.81
Working Capital	-2.76M	522.00K	9.30M	6.13M	22.53M	34.49M	45.82M	8.32M	35.27M	46.06M	58.53M	68.89M
Leverage & Debt
Debt to Equity	-10.73	13.91	8.16	5.49	1.78	1.19	1.84	2.61	0.97	0.82	0.79	0.59
Interest Coverage TTM	-130.52	-89.90	-74.20	-62.50	-61.80	-60.47	-64.39	-55.62	-58.52	-44.08	-32.38	-24.63
Debt Ratio	1.10	0.93	0.89	0.85	0.64	0.54	0.48	0.72	0.49	0.45	0.44	0.37
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.02	0.01
Per Share Metrics
Diluted EPS TTM	-1.59	-1.66	-2.73	-1.81	-2.24	-5.47	-11.49	-15.49	-12.46	-14.10	-16.01	-15.86
Free Cash Flow Per Share TTM	-1.43	-1.20	-1.94	-1.38	-1.33	-4.37	-9.01	-7.64	-9.69	-11.67	-14.52	-16.85
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-165,724.24%	-356,237.50%	-	-	-	-	-	-12,714.20%	-11,006.21%	-6,168.13%	-3,620.73%	-6,416.00%
Net Profit Margin TTM	-150,193.94%	-322,168.75%	-	-	-	-	-	-14,179.20%	-6,796.30%	-4,226.03%	-2,774.62%	-5,153.54%
Growth Metrics
Net Revenue Growth (1Y)	-	-	-	-100.00%	-100.00%	-100.00%	-100.00%	-63.48%	-70.04%	-56.03%	-22.06%	-69.91%
Net Income Growth (1Y)	-15.02%	-5.92%	16.38%	-32.89%	2.40%	-14.98%	-25.71%	0.49%	-21.19%	-1.04%	22.07%	-25.59%
EPS Growth (1Y)	-28.83%	-69.58%	-76.21%	-88.29%	-82.05%	-61.19%	-28.28%	-2.36%	-23.68%	-4.58%	-28.17%	-27.35%
Valuation Metrics
P/E TTM	-0.69	-0.49	-0.38	-0.78	-0.94	-0.61	-0.31	-0.15	-0.22	-0.27	-0.41	-0.26
P/B TTM	-10.07	9.80	4.18	4.55	2.23	0.89	0.63	0.65	0.29	0.31	0.44	0.22
P/S TTM	1,038.16	1,571.81	-	-	-	-	-	20.69	15.06	11.30	11.43	13.42
Market Cap	34.26M	25.15M	23.38M	36.98M	55.03M	33.64M	16.13M	10.34M	12.62M	17.23M	29.28M	18.37M
Enterprise Value	26.37M	12.69M	6.96M	21.20M	29.93M	-3.71M	21.59M	-3.59M	-6.69M	-6.39M	-10.07M	-27.34M
Calculated Values
Free Cash Flow TTM	-44.62M	-37.07M	-43.64M	-36.23M	-34.65M	-43.78M	-41.42M	-34.95M	-44.32M	-53.32M	-64.43M	-74.93M
Net Debt	-7.89M	-12.46M	-16.42M	-15.78M	-25.11M	-37.35M	5.46M	-13.94M	-19.31M	-23.62M	-39.35M	-45.71M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-02-06Sale

Owner: Rajangam, Kanya

Title: Pres. & Chief Med. & Dev. Off.

Shares: 182

Price/Share: $4.37

Value: $795.34

Shares Owned: 8,621

Relationship: Officer

Ownership: Direct

2025-02-06Sale

Owner: Lu, Timothy K

Title: CEO

Shares: 545

Price/Share: $4.36

Value: $2,376.20

Shares Owned: 82,082

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-02-06	Rajangam, Kanya	Officer	Pres. & Chief Med. & Dev. Off.	Direct	Sale	182	4.37	$795.34	8,621	4
2025-02-06	Lu, Timothy K	Director,Officer	CEO	Direct	Sale	545	4.36	$2,376.20	82,082	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

18.12%

Inst. Shares: 5,613,378

Shares Outstanding: 30,971,573

2025-12-31

24.77%

Inst. Shares: 5,569,956

Shares Outstanding: 22,483,391

2025-09-30

21.39%

Inst. Shares: 5,609,415

Shares Outstanding: 26,228,274

2025-06-30

24.86%

Inst. Shares: 6,484,113

Shares Outstanding: 26,081,273

2025-03-31

56.56%

Inst. Shares: 5,663,433

Shares Outstanding: 10,012,908

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	5,613,378	30,971,573	18.12%
2025-12-31	5,569,956	22,483,391	24.77%
2025-09-30	5,609,415	26,228,274	21.39%
2025-06-30	6,484,113	26,081,273	24.86%
2025-03-31	5,663,433	10,012,908	56.56%
2024-12-31	653,841	4,595,946	14.23%
2024-09-30	1,065,287	4,577,122	23.27%
2024-06-30	1,036,276	4,572,010	22.67%
2024-03-31	1,093,543	4,570,744	23.92%
2023-12-31	1,140,562	4,437,106	25.71%
2023-09-30	883,901	4,447,223	19.88%
2023-06-30	870,385	4,427,726	19.66%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Senti Biosciences Holdings, Inc. (SNTI) — SEC Financial Statements & Analysis

Senti Biosciences Holdings, Inc. (SNTI) is a biological products, (no diagnostic substances) company, incorporated in DE. Senti Biosciences Holdings, Inc. trades on Nasdaq as: SNTI. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Senti Biosciences Holdings, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of -10.73x, a Price-to-Sales (P/S) ratio of 1038.16x (TTM), a Price-to-Book (P/B) ratio of -10.07x (TTM), at a market cap of $34.26M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: -10.73x
P/S TTM: 1038.16x
P/B TTM: -10.07x
Market Cap: $34.26M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Senti Biosciences Holdings, Inc. in?

Senti Biosciences Holdings, Inc. (SNTI) operates in the Biological Products, (No Diagnostic Substances) industry.

What is SNTI's market cap?

Senti Biosciences Holdings, Inc. (SNTI) has a market capitalization of $34.26M as of 2026-06-30.

What exchange does SNTI trade on?

Senti Biosciences Holdings, Inc. (SNTI) trades on the Nasdaq.

Where is Senti Biosciences Holdings, Inc. incorporated?

Senti Biosciences Holdings, Inc. is incorporated in DE.